Relationship of Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphism and Nontraumatic Lunatum Avascular Necrosis

Wagner, 2005, A historical report on Robert Kienböck (1871-1953) and Kienböck’s disease, J Hand Surg Am, 30, 1117, 10.1016/j.jhsa.2005.08.002 Lamas, 2007, The anatomy and vascularity of the lunate: considerations applied to Kienböck’s disease, Chir Main, 26, 13, 10.1016/j.main.2007.01.001 Asano, 2004, Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects, Transplantation, 77, 220, 10.1097/01.TP.0000101433.99651.96 Liang, 2013, Association between PAI-1 4G/5G polymorphisms and osteonecrosis of femoral head: a meta-analysis, Thromb Res, 132, 158, 10.1016/j.thromres.2013.06.023 Ferrari, 2002, Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients, Transplantation, 74, 1147, 10.1097/00007890-200210270-00016 Glueck, 1999, The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis, Clin Orthop Relat Res, 366, 133, 10.1097/00003086-199909000-00017 Arnaiz, 2014, Imaging of Kienböck disease, AJR Am J Roentgenol, 203, 131, 10.2214/AJR.13.11606 Parpugga, 2015, The effect of PAI-1 4G/5G polymorphism and clinical factors on coronary artery occlusion in myocardial infarction, Dis Markers, 2015, 260101, 10.1155/2015/260101 Mohammed Suhail Akhter MS, 2010, Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis, Clin Appl Thromb Hemost, 16, 184, 10.1177/1076029609333673 Cale, 2007, Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent, Curr Drug Targets, 8, 971, 10.2174/138945007781662337 Naran, 2008, The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity, Atherosclerosis, 196, 155, 10.1016/j.atherosclerosis.2007.03.024 Kim, 2011, Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head, BMC Musculoskelet Disord, 12, 160, 10.1186/1471-2474-12-160 Dawson, 1991, Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity, Arterioscler Thromb, 11, 183, 10.1161/01.ATV.11.1.183 Li, 2017, Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility, Medicine, 96, e7047, 10.1097/MD.0000000000007047 Golay, 2016, The radiological prevalence of incidental Kienböck disease, Arch Bone Joint Surg, 4, 220